Abstract: The present invention is directed to a coated conduit comprising: a) a conduit having an interior and exterior surface; and b) a cured coating formed from a reaction mixture that is applied to at least one surface of the conduit. The reaction mixture comprises: i) a filler material comprising fibers ranging in length from 0.1 to 15.54 cm and having an aspect ratio of at least 5; and ii) a reactive component that demonstrates a tack-free time of less than five minutes at a temperature of 20 to 25° C. The present invention is also directed to a method of repairing or reinforcing a conduit, comprising: (a) applying a curable coating composition to at least one surface of the conduit, wherein the curable coating composition is formed from the reaction mixture described above; and (b) allowing the curable coating composition to at least partially cure by exposing the composition to ambient conditions.

Abstract: The present invention is directed to a coated conduit comprising: a) a conduit having an interior and exterior surface; and b) a cured coating formed from a reaction mixture that is applied to at least one surface of the conduit. The reaction mixture comprises: i) a filler material comprising fibers ranging in length from 0.1 to 15.54 cm and having an aspect ratio of at least 5; and ii) a reactive component that demonstrates a tack-free time of less than five minutes at a temperature of 20 to 25° C. The present invention is also directed to a method of repairing or reinforcing a conduit, comprising: (a) applying a curable coating composition to at least one surface of the conduit, wherein the curable coating composition is formed from the reaction mixture described above; and (b) allowing the curable coating composition to at least partially cure by exposing the composition to ambient conditions.

Abstract: The present invention is directed to a coated conduit comprising: a) a conduit having an interior and exterior surface; and b) a cured coating formed from a reaction mixture that is applied to at least one surface of the conduit. The reaction mixture comprises: i) a filler material comprising fibers ranging in length from 0.1 to 15.54 cm and having an aspect ratio of at least 5; and ii) a reactive component that demonstrates a tack-free time of less than five minutes at a temperature of 20 to 25° C. The present invention is also directed to a method of repairing or reinforcing a conduit, comprising: (a) applying a curable coating composition to at least one surface of the conduit, wherein the curable coating composition is formed from the reaction mixture described above; and (b) allowing the curable coating composition to at least partially cure by exposing the composition to ambient conditions.

Abstract: The present invention is directed to a coated conduit comprising: a) a conduit having an interior and exterior surface; and b) a cured coating formed from a reaction mixture that is applied to at least one surface of the conduit. The reaction mixture comprises: i) a filler material comprising fibers ranging in length from 0.1 to 15.54 cm and having an aspect ratio of at least 5; and ii) a reactive component that demonstrates a tack-free time of less than five minutes at a temperature of 20 to 25° C. The present invention is also directed to a method of repairing or reinforcing a conduit, comprising: (a) applying a curable coating composition to at least one surface of the conduit, wherein the curable coating composition is formed from the reaction mixture described above; and (b) allowing the curable coating composition to at least partially cure by exposing the composition to ambient conditions.

Abstract: The invention provides certain pyrazine-2-carboxamide compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein A, B, and X are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk).

Abstract: The invention provides certain pyrazine-2-carboxamide compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein A, B, and X are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk).

Abstract: Provided are triazole derivatives of Formula I which are potent inhibitors of spleen tyrosine kinase and pharmaceutical composition. The triazole derivatives are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis, and cancer.

Abstract: The present invention provides novel pyrazole derivatives of formula I which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis, and cancer.

Abstract: The present invention provides compounds of Formula (I), which are prodrugs of trans-4-[(1R)-(6-{[4-(difluoromethyl)pyridin-2-yl]amino}-4-methyl-2,3?-bipyridin-6?-yl)-1-hydroxyethyl]cyclohexanecarboxylic acid, a potent inhibitor of Syk. The compounds are useful in the treatment and prevention of diseases mediated by the enzyme, such as asthma, COPD, rheumatoid arthritis and cancer.

Abstract: Provided are triazole derivatives of Formula I which are potent inhibitors of spleen tyrosine kinase and pharmaceutical composition. The triazole derivatives are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis, and cancer.

Abstract: The present invention provides novel pyrazole derivatives of formula I which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis, and cancer.

Abstract: The instant invention provides compounds of formula I which are JAK3 inhibitors. Specifically, the compounds of formula I are pyrrolo[2,3-d]pyrimidine derivative compounds. The instant invention also provides methods of treating JAK-mediated diseases such as rheumatoid arthritis, asthma, COPD and cancer, by administering the pyrrolo[2,3-d]pyrimidine-derivative compounds of formula I.

Abstract: The instant invention provides compounds of formula I which are JAK3 inhibitors. Specifically, the compounds of formula I are pyrrolo[2,3-d]pyrimidine derivative compounds. The instant invention also provides methods of treating JAK-mediated diseases such as rheumatoid arthritis, asthma, COPD and cancer, by administering the pyrrolo[2,3-d]pyrimidine-derivative compounds of formula I.

Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt thereof. Compounds of formula I are inhibitors of Janus kinases and as such are useful for the treatment of various diseases and conditions mediated by said enzymes, such as rheumatoid arthritis, asthma, COPD, ALS, and the like.